E-Service Bank: A Study on the Quality of Digital Banking Service during the Covid-19 Pandemic

Objective: This research aims to analyze the perception of quality in e-banking services. For this, a theoretical model was proposed using adapted and validated constructs of the quality of e-banking services, based on the set of three variables: security, ease of use and efficiency.Method/approach: Cross-sectional descriptive quantitative research, through the collection of primary data via google forms. The questionnaire obtained the amount of 367 answers, of which 348 were valid. Statistical techniques were used for data analysis and the results revealed that security, ease of use and efficiency have a positive effect on the quality of the e-service. In addition, the innovation variable was tested and found that it influences the quality and satisfaction of e-banking services.Main Results: The results reveal that the constructs positively influence the quality of the e -service and reinforce the importance of innovation in online banking services, which allow the customer more agility, efficiency and security in banking transactions. Theoretical/practical/social contributions: As a theoretical contribution, this work tested the ServQual scale in the e-service adapted for the Brazilian market. Regarding managerial practices, this research will contribute to banks that use e-banking services, since they build their strategies based on the digital service. Originality/relevance: The present study innovates in testing the ServQual scale in the e -service adapted for the Brazilian market. As well as in carrying out the analysis, the insertion of innovation as a moderator in the perception of quality and satisfaction in the digital banking service.

Evaluation of myocardial work in patients recovered from the severe form of COVID-19

Background/Introduction: The impact of COVID-19 goes beyond its acute form, and can lead to the persistence of symptoms and the emergence of systemic disorders, defined as Post-Covid or Long-Covid. Purpose(s): Assess the late impact on the cardiorespiratory system of patients recovered from severe Covid. Method(s): We performed cross-sectional study that included patients over 18 years of age who recovered from the severe form of COVID-19 after at least 60 days of their discharge. Patients and healthy controls were enrolled to perform transthoracic echocardiography (TTE) and cardiopulmonary exercise testing (CPET). Result(s): A total of 52 patients and 24 controls were enrolled. The standard TTE parameters (end diastolic diameters, left ventricular ejection fraction, diastolic function and right ventricular systolic function) showed no difference when compared to the control group. When analyzing the myocardial work, there was a higher Wasted MW (GWW): 135 mmHg% vs 84.5 mmHg% (p=0.002), with lower MW Efficiency (GWE): 94 vs. 96 (p=0.003);as well as lower values of global strain: Cases = 18.6% vs. 20.1% (p=0.009). No differences were found in the Constructive MW (GWC) and MW Global Index (GWI). In the CPET data we found lower peak values for the VO2: 24 ml/kg/min vs. 32.75 ml/kg/min (p<0.001);for the Heart Rate: 162 bpm vs. 175 bpm (p<0.001);for the Ventilation: 79.3 L/min vs. 109.85 L/min (p<0.001) and Respiratory Exchange Ratio: 1.12 vs. 1.19 (p=0.004). There was no difference in the maximum load reached, neither in the oxygen pulse values and in the Ve/CO2 slope. In relation to the oxygen kinetics, there was a significant reduction in OUES%: 85% vs. 98% (p=0.03);as well as an extended T1/4: 112 s vs. 88.5 s (p<0.001);and a slowing of the fall in heart rate in recovery time, as measured by the Heart Rate decay: -17.32 bpm vs. -22.08 bpm (p=0.005). Conclusion(s): Patients recovered from the severe form of COVID-19 had higherGWWwith lower efficiency (GWE). Such findings, added to changes in oxygen kinetics during exercise, may point to a possible cardiocirculatory mechanism associated with decreased aerobic capacity.

Safety and efficacy of REZUM for the treatment of BPH in an Australian cohort

Introduction & Objectives: Minimally invasive transurethral therapies for benign prostatic hypertension are becoming increasingly common in Europe and America. They may be performed under local anaesthetic and provide a good alternative to invasive procedures in a COVID era. REZUM, a minimally invasive transurethral water-vapor therapy, has been shown to be a safe and effective treatment for BPH, especially where preserved sexual function is a priority. Although short-term clinical outcomes are promising, long-term data from robust studies is lacking. In Australia, there are few providers of REZUM, which utilises steam injections to reduce prostatic tissue. This study aims to investigate the safety and efficacy of REZUM in an Australian cohort. Methods: A clinical audit was conducted of 50 patients who underwent REZUM to treat symptoms of BPH over a 12-month period. Procedures were performed under general anaesthetic. Demographics, comorbidities, sexual function, prostate volume, PSA, voiding flow rate, post-void residual volume and International Prostate Symptom Score were extracted from medical records, in addition to patient's reasons for seeking minimally invasive treatment. Corresponding post-operative data was collected. Descriptive statistics of the cohort were obtained using Stata 16.0. Paired t-test was used to identify if there was a significant difference between IPSS scores pre- and postprocedure Results: Patients accessing treatment ranged from 48 to 84 years (mean 64.6). Median prostate volume was 55mL (inter-quartile range 45-78mls) and mean International Prostate Symptom Score (IPSS) was 20.3. 28% of the cohort cited concern for ejaculatory function, either from medication side effects or TURP, as their primary reason for seeking minimally invasive treatment. A further 25% of the cohort was additionally concerned about other side effects from medications and/or TURP or had experienced medication failure. The mean follow up period was 6 months (range 6-weeks-26 months). 69% of men were satisfied with their symptom improvement at the time of review, with the expectation of ongoing improvement in men who had attended a 6-week post-operative review only. Postprocedure mean IPSS was 7.9 (range 2-33). Mean reduction in IPSS score post-procedure was 12.7 points (p<0.001). 3 men experienced complications (retention, infection, bulbar stricture). Conclusions: REZUM provides a safe alternative to traditional invasive prostatic treatments. It may be performed under local anaesthetic, providing an effective alternative in a COVID era. Men concerned about medications, more invasive treatments and ejaculatory dysfunction are increasingly seeking relief from this minimally invasive option and experiencing good outcomes including significant symptom improvement sustained over medium-term follow up.

HUMORAL IMMUNITY AGAINST COVID-19 6 MONTHS AFTER THE PFIZER BNT162B2 VACCINE IN HAEMODIALYSIS PATIENTS: DATA FROM 5 DIALYSIS UNITS. IS THERE A ROLE FOR HDF IN THE COVID-19 PANDEMIA?

BACKGROUND AND AIMS: Haemodialysis (HD) patients tend to be old, have weakened immune systems and suffer from multiple comorbidities, making them particularly prone to infections and death by the Coronavirus disease 2019 (COVID-19). Global vaccination against SARS-CoV2 has been underway, but long-term data in dialysis patients are still scant. We aimed to study the seroconversion with the Pfizer BNT162b2 vaccine in HD patients of 5 Dialysis Centres after the first 2 doses and monitor the immune responses and clinical data during the following 7 months. We also investigated the security of the vaccine. METHOD: We included 404 patients on chronic HD. All patients received 2 shots of the Pfizer BNT162b2 vaccine, separated by 21 days. Serologic tests were run using Quant II IgG anti-Spike SARS-CoV-2 assay by Abbott. Blood was drawn 21 days after the first dose (D22), 21 days after the second dose (D43), 3 and 6 months after the first dose (M3 and M6, respectively). We asked the patients to answer written questionaries about the symptoms reported during the 7 days after each vaccination. RESULTS: 60.6% of our patients were male and the median age was 70 years (min 19, max 97). 26 patients (6.4%) had previously been infected with COVID-19. 6 of them (23.1%) needed hospitalization. At 7 months follow-up, there were 3 new cases and 1 death (the one who died had negative antibody counts at M3). Maximum response to the vaccine was seen at D43, with 97.3% of the patients showing positive antibody titers. At 6 months, 91.5% still had positive antibodies. As is reported in Table 1, the following patients had higher antibody titers at D43 and M6: patients with COVID-19 before the first vaccine, younger patients, patients with higher albumin levels, patients on HDF versus HD. Patients on HDF had higher titers at all moments during the 6 months (Figure 1). Patients with cancer without antineoplasic treatment in the last 6 months showed lower rates of seroconversion at D43: OR: 0.117 [95% confidence interval (95% CI) 0.016-0.863]} and M6 (OR: 0.203, 95% CI 0.049-0.842]. Patients whose levels of C-reactive protein was ≤ 2.8 mg/dL had more probability of seroconversion at D43 (OR: 7.840, 95% CI 1.839-33.419;P < 0.005) as well as those with a higher (better) Karnofsky scale (OR 1.062, 95% CI 1.016-1.110). 43.4% of the patients reported at least one side effect after the first shot and 64.6% after the second shot. A total of 69.1% had at least one-side effect on the first or second shot. All the reported reactions were mild and transitory. CONCLUSION: Patients on HD respond surprisingly well to anti-COVID-19 vaccination and present only mild side effects. Further studies should analyze the impact of HDF on immune responses, since our work suggests that this type of dialysis may have a positive and protective long-term role on this population.

Delirium in COVID-19: psychopharmacology considerations

IntroductionDelirium is characterized by fluctuating disturbance of consciousness, inattention, reduced awareness, hallucinations or delusions, occurring in 20% of hospital admissions. Central nervous system symptoms are the main form of neurologic injury in patients with COVID-19 and a significant portion of these patients presents with delirium. COVID-19 infection’s course and symptoms, as well as patient comorbidities can facilitate its onset, which is exacerbated by the frequent need for higher doses of sedation to suppress severe cough.ObjectivesTo summarize the most recent practices for management of delirium in COVID-19 infected patients, with emphasis on the psychopharmacology approach.MethodsSelective literature review via PubMed search, using the terms “delirium, neurological disorders, psychopharmacology and COVID-19”.ResultsCOVID-19 associated delirium can be presented in its hyperactive type with exuberant agitation, but also with additional clinical features such as rigidity, akinetic mutism, abulia and alogia. Psychopharmacological approaches may be needed for patients with agitation when there’s intractable stress or risk to self or others. In this group of patients, melatonin, alfa-2 agonists and low potency antipsychotics have been used as first line treatment. Trazodone, valproate, dopamine agonists, amantadine can be used. Other approaches such as correction of vitamin deficiencies and remdesivir can also play a role.ConclusionsDelirium remains frequently unrecognized. In the pandemic context of COVID-19 it is important to consider this infection as a cause of delirium and mind the misdiagnosis as a psychiatric condition. One should look for atypical features and be more thoughtful about the psychopharmacological approach.

Sociodemographic variables associated altered tolerance in friendship relations in the COVID-19 pandemic

Objective: to verify the association between sociodemographic variables and altered tolerance in friendship relationships during the COVID-19 pandemic. Method: cross-sectional study conducted in the five Brazilian macro-regions, from June to July 2020, through the application of a sociodemographic questionnaire, a semi-structured questionnaire and the Instrument for Assessing tolerance in friendship relationships. Fischer’s chi-square and exact tests were used for data analysis. Results: 88.9% considered satisfactory tolerance in relationships in the home environment, 82.8% had help from friends to overcome tensions, 73% perceived a change in relationships during quarantine. This change was higher among heterosexuals (p=0.001), residents in the Southeast and Midwest (p=0.001), with complete higher education (p=0.004), linked to private institutions (p<0.001) and who received help from friends during quarantine (p<0.001). Conclusion: sociodemographic factors and social support received from friends are associated with changes in tolerance in friendship relationships during the pandemic. © 2020 Universidade Federal da Bahia. All rights reserved.

Maternal and child health in the context of COVID-19 pandemic: evidence, recommendations and challenges. (Special Issue: Transparency in research and publications on COVID-19.)

Objectives: To present the main evidence, recommendations and challenges for maternal and child health in the context of COVID-19 pandemic.

Maternal and child health in the context of COVID-19 pandemic: evidence, recommendations and challenges

Objectives: to present the main evidence, recommendations and challenges for maternal and child health in the context of COVID-19 pandemic. Methods: narrative review of national and international documents and reflections on the theme. Results: the coexistence ofpregnancy/puerperium and COVID-19 infection establishes many challenges. It is extremely important that the conduct should be individually adopted, covering all aspects of health in the mother-child binomial, estimating risks and benefits of each decision. Until now, it is recognized that natural childbirth should be encouraged and breastfeeding maintained, if adequate hygienic-sanitary care is ensured. Cesarean delivery and the isolation and separation of the mother-child contact without breastfeeding, will only be eligible when the clinical status of the mother or child is critical. The child must be included in all stages of health care, as this commonly asymptomatic group plays an important role in the family's transmissibility of the disease. Routine immunization should be provided, as well as clinical assistance when necessary, and families must be assisted in favor of their well-being. Conclusion: at the moment, it is not possible to measure the consequences of this new pandemic on maternal and child health, demanding attention to its evolution and new evidences about the implications in mother and child care. © 2021, Instituto Materno Infantil Professor Fernando Figueira. All rights reserved.